Arrowhead Pharmaceuticals is a biopharmaceutical company that designs medicines using RNA interference, a technique that reduces the production of specific proteins involved in disease. Its pipeline focuses on liver and metabolic conditions, including treatments aimed at lowering harmful blood fats and addressing other disorders with few options. The company carries out its own research and development and works with partners on some programmes. It is based in Pasadena, California, in the United States.
Arrowhead Pharmaceuticals, Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A2RR34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1149 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
32/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-22.4%
From 52-week high-38.0%
MomentumWeak
36/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-35.1%
6-month return-23.1%
12-month, skipping last month66.1%
Stability (higher is calmer)Weak
28/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)64.7%
Worst drawdown, 1 year (smaller is calmer)-38.0%
LiquidityWeak
42/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.02M BRL
Zero-volume days25.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 25.14 – 59.95Daily closes, split-adjusted
Signals
50-day average47.96
200-day average46.37
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.86
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 8 bearish
Monthly
Neutral
4 bullish · 1 neutral · 3 bearish
Moving averages (daily)
SMA 10
37.15
Bearish
EMA 10
37.53
Bearish
SMA 20
40.10
Bearish
EMA 20
39.97
Bearish
SMA 50
47.96
Bearish
EMA 50
44.93
Bearish
SMA 100
49.72
Bearish
EMA 100
46.80
Bearish
SMA 200
46.37
Bearish
EMA 200
44.21
Bearish
Oscillators (daily)
RSI (14)
24.28
Bullish
MACD (12, 26)
-3.33
Bearish
Momentum (12)
-17.58
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-88.82
Neutral
Pivot points (classic, last session)
S3
36.00
S2
36.00
S1
36.00
Pivot
36.00
R1
36.00
R2
36.00
R3
36.00
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
